Together, these findings establish the DANCR–ABL2 axis as a central regulator of cytoskeletal reorganization and metastatic progression in neuroblastoma, bridging lncRNA function to kinase-driven cytoskeletal plasticity. The gene discussed is DANCR; the disease is neuroblastoma.